🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07597213
Recruiting Not applicable

Hyaluronic Acid as an Adjunct to Non-Surgical Periodontal Therapy in Smokers

NCT07597213 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-13
Last updated
2026-08-18

Condition(s) studied

Hyaluronic AcidPeriodontal TherapyOral MicrobiotaOxidative StressMetallothionein8-OHdGPeriodontitis

Investigational drug(s) / intervention(s)

Scaling and Root PlaningHyaluronic Acid (HYADENT BG)

Scaling and Root Planing: Scaling and root planing is a conventional gold-standard treatment for periodontitis. As part of this procedure, subgingival plaque and tartar are removed and root surfaces are planed.

Hyaluronic Acid (HYADENT BG): Hyaluronic acid will be locally applied to periodontal pockets as an adjunct to non-surgical periodontal treatment, aiming to support periodontal healing. After completion of scaling and root planing, the material will be delivered subgingivally to designated test sites.

Study summary

The goal of this clinical trial is to evaluate whether hyaluronic acid (HA) improves periodontal healing in people with periodontal disease who smoke. Moreover, the effects of HA on biomolecules and bacteria levels will be assessed during the follow up period.

The main questions it will answer are:

Will periodontal sites treated with HA gel after non-surgical periodontal treatment (NSPT) lead to better outcomes in clinical parameters compared to the sites treated with NSPT only in smokers?

Will adjunctive use of HA gel reduce oxidative stress markers and bacteria levels during follow-up?

Researchers will compare periodontal sites receiving NSPT with adjunctive HA gel application to sites receiving NSPT alone to determine whether HA provides additional clinical, biochemical and microbiological benefits.

Participants will:

* first receive full-mouth NSPT then, randomization will be performed in selected jaw to determine the test sites. These two interproximal test sites will additionally receive HA gel application.
* attend follow-up visits at 1, 3 and 6 months for clinical periodontal measurements and to provide gingival crevicular fluid samples (GCF) and subgingival samples.

The GCF samples will be evaluated for Metallothionein (MT) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels and subgingival samples for periodontal pathogens.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: 1. Individuals who sign the informed consent form 2. Participants who are systemically healthy 3. Participants who smoke (for \>5 years and ≥10 cigarettes per day) 4. Participants diagnosed with Stage III or Stage IV periodontitis 5. Participants with at least 20 natural teeth present in the mouth (excluding third molars) 6. Participants with two non-adjacent interproximal sites in each quadrant of either jaw, presenting probing depth (PD) and clinical attachment level (CAL) ≥6 mm, and with no caries, restorations, or furcation involvement Exclusion Criteria: 1. Individuals who do not sign the informed consent form 2. Individuals having any systemic disease 3. Participants who have used antibiotics within the last 3 months 4. Participants who have received any periodontal treatment within 6 months prior to the study 5. Participants who are pregnant or lactating

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Periodontology, Faculty of Dentistry, Marmara University Istanbul Turkey (Türkiye) Recruiting

More Marmara University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07597213 on ClinicalTrials.gov ↗ ← All trials in Turkey